Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07208682 · ClinicalTrials.gov registry record · NA
Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings
A NA study of Bladder Perforation and Retropubic Midurethral Sling, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07208682 is a NA study of Bladder Perforation and Retropubic Midurethral Sling that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07208682, a NA study of Bladder Perforation and Retropubic Midurethral Sling, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Retropubic midurethral slings are a common and effective treatment for stress urine incontinence. The trocar that is attached to the mesh material can hit the bladder which is called a perforation. While there are no known long-term adverse outcomes from trocar-induced bladder perforations, it can prolong operative time and bleeding. At academic institutions, it has been reported that trocar-induced perforations occurs in the range of 14-34% of the time. This study is a randomized controlled trial to see if an intervention can decrease trocar-induced bladder perforation rates. The primary outcome of this study is to measure trocar-induced bladder perforations in subjects undergoing a retropubic midurethral sling. Subjects would be randomized to either receive the hydrodissection in a standardized manner or to not receive it. Secondary outcomes include bothersome urinary symptoms, pain, estimated blood loss during surgery, and voiding trial results
Conditions Studied
Interventions
- PROCEDURE retropubic hydrodissection
Study Locations (1)
Massachusetts
- University of Massachusetts Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-04-03 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07208682
The ClinicalTrials.gov registry entry for NCT07208682 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bladder Perforation appearing as the primary indexed condition, and to 1 intervention - of which retropubic hydrodissection is the first listed.
NCT07208682 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07208682 about?
NCT07208682 is a clinical study titled "Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings". Retropubic midurethral slings are a common and effective treatment for stress urine incontinence. The trocar that is attached to the mesh material can hit the bladder which is called a perforation. While there are no known long-term adverse outcomes from trocar-induced bladder perforations, it can p...
What is the current status of trial NCT07208682?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-04-03. Estimated completion is 2027-06.
What conditions does trial NCT07208682 study?
This clinical trial studies the following conditions: Bladder Perforation, Retropubic Midurethral Sling, Retropubic Hydrodissection.
What interventions are being tested in trial NCT07208682?
The interventions under investigation include: retropubic hydrodissection (PROCEDURE).
Who is sponsoring clinical trial NCT07208682?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07208682 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.